Sterling Capital Management LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 19.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 70,855 shares of the company's stock after buying an additional 11,642 shares during the quarter. Sterling Capital Management LLC's holdings in GE HealthCare Technologies were worth $5,539,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in GEHC. CoreFirst Bank & Trust bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth approximately $25,000. Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after buying an additional 168 shares in the last quarter. Runnymede Capital Advisors Inc. purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at about $28,000. Bank of Jackson Hole Trust purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at about $32,000. Finally, Flagship Wealth Advisors LLC purchased a new position in GE HealthCare Technologies in the fourth quarter worth about $34,000. 82.06% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently commented on the company. Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research note on Monday. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their target price for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $97.27.
View Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Stock Up 1.4 %
NASDAQ GEHC traded up $0.86 during trading hours on Thursday, hitting $62.34. 1,866,800 shares of the company were exchanged, compared to its average volume of 3,810,366. The firm has a market cap of $28.54 billion, a price-to-earnings ratio of 14.39, a PEG ratio of 3.19 and a beta of 1.14. The company has a 50 day moving average of $80.26 and a two-hundred day moving average of $83.51. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.22%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles

Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.